Hereditas (Beijing) (遗传) 2010/32:5 PP.461-466
To explore the relationship between genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR), reduced folate carrier1 (RFC-1), methionine synthase (MTR) involved in folate metabolism and the risk of offsprings of young Chinese women with Down syndrome (DS) through a case-control study, the polymorphisms of MTHFR 677C>T, MTRR 66A>G, RFC-1 80G>A, and MTR 2756A>G in 60 mothers of children with DS and 68 control mothers were investigated by PCR-RFLP. Significant differences in alle-lic frequencies were present between the cases and controls for MTHFR (P<0.05), but not in allelic frequencies for MTRR, RFC-1, and MTR. Homozygous MTHFR 677C>T polymorphism was more prevalent among the mothers of children with DS than among the control mothers, with an odds ratio of 3.51 (OR=3.51, 95% CI=1.30~9.46, P<0.05). No significant association was observed in the combined heterozygotes. In addition, the homozygous MTRR 66A>G polymorphism was independently associated with a 3.16-fold increase in estimated risk (OR=3.16, 95% CI=1.20~8.35, P<0.05). The increased risk of DS for homozygous RFC-1 80G>A was not associated with MTR 2756A>G. Positive interactions were found for the following genotype-pairs: MTHFR(CT+TT)/MTRR GG, MTHFR (CT+TT)/RFC-1 AA, MTHFR CC/MTR(AG+GG), MTHFR (CT+TT)/MTR AA, MTRR GG/MTR AA, and RFC-1 AA/MTRAA. In conclusion, MTHFR 677C>T and MTRR 66A>G polymorphisms are two independent risk factors for DS pregnancies in young women, but RFC-1 80G>A and MTR 2756A>G polymorphism are not independent risk factor. A role for combined genotypes in the risk of DS pregnancies cannot be excluded.
 Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, Coppedè F, Sbrana I. Susceptibility to chromo-some malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol Aging, 2006, 27(5): 710-716.
 James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be ma-ternal risk factorsfor Down syndrome. Am J Clin Nutr, 1999, 70(4): 495-501.
 Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. Polymorphisms in genes involved in folate metabolism as maternal risk fac-tors for Down syndrome. Am J Hum Genet, 2000, 67(3): 623-630.
 Scala I, Granese B, Sellitto M, Salome S, Sammartino A, Pepe A, Mastroiacovo P, Sebastio G, Andria G. Analysis of seven maternal polymorphisms of genes involved in ho-mocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med, 2006, 8(7): 409-416.
 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in me-thylenetetrahydrofolate reductase. Nat Genet, 1995, 10(1): 111-113.
 Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP. A polymorphism (80G→A) in the reduced folate carrier gene and its asso-ciations with folate status and homocysteinemia. Mol Genet Metab, 2000, 70(4): 310-315.
 Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A, 2003, 121(3): 219-224.
 史庆华, 许波, 杨庆岭, 陈大蔚, 侯贺礼, 马铁梁, 郑媛. 非整倍体和人类生殖健康. 中国科学技术大学学报, 2008, 38(8): 388-988.
 郑陈光, 覃靖, 杜娟, 陈科, 陈赤, 田晓先, 相蕾, 孙亮, 杨泽. 南宁地区唐氏综合征患者的细胞遗传学研究. 遗传, 2009, 31(3): 261-264.
 Wang X, Thomas P, Xue J, Fenech M. Folate deficiency-induces aneuploidy in human lymphocytes in vi-tro-evidenceusing cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res, 2004, 551(1-2): 167-180.
 Fenech M. The role of folic acid and Vitamin B12 in ge-nomic stability of human cells. Mutat Res, 2001, 475(1-2): 57-67.
 Rai AK, Singh S, Mehta S, Kumar A, Pandey LK, Raman R. MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet, 2006, 51(4): 278-283.
 da Silva LR, Vergani N, Galdieri Lde C, Ribeiro Porto MP, Longhitano SB, Brunoni D, D'Almeida V, Alvarez Perez AB. Relationship between polymorphisms in genes in-volved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet A, 2005, 135(3): 263-267.
 Chango A, Fillon-Emery N, Mircher C, Blehaut H, Lam-bert D, Herbeth B, James SJ, Rethore MO, Nicolas JP. No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers. Br J Nutr, 2005, 94(2): 166-169.
 Takamura N, Kondoh T, Ohgi S, Arisawa K, Mine M, Ya-mashita S, Aoyagi K. Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr, 2004, 43(5): 285-287.
 Coppede F, Marini G, Bargagna S, Stuppia L, Minichilli F, Fontana I, Colognato R, Astrea G, Palka G, Migliore L. Folate gene polymorphisms and the risk of Down syn-drome pregnancies in young Italian women. Am J Med Genet A, 2006, 140(10): 1083-1091.
 Wang SS, Qiao FY, Feng L, Lv JJ. Polymorphisms in genes involved in folate metabolism as maternal risk fac-tors for Down syndrome in China. J Zhejiang Univ Sci B, 2008, 9(2): 93-99.
 梁蓉, 郁卫东, 杜军保, 杨丽君, 尚美, 宋眆, 王林, 郭静竹. 叶酸代谢相关酶基因多态性与唐氏综合征发生易感性的关系. 实用医学杂志, 2006, 22(12): 1372-1375.
 裴丽君, 李竹. 还原叶酸载体基因(RFC1)与神经管和颅面畸形病因学关系的研究进展. 遗传, 2004, 26(2): 239-243.
 裴丽君, 任爱国, 朱慧萍, 郝玲, 赵文睿, 李竹, 侯广旺, 张伯兰, 蒋琰瑛, 吴立民, 潘玉娟, 张梦兰. 中国南北方人群还原叶酸载体基因多态性分布研究. 中华流行病学杂志, 2004, 25(6): 499-502.
 Coppedè F, Migheli F, Bargagna S, Siciliano G, Antonucci I, Stuppia L, Palka G, Migliore L. Association of maternal polymorphisms in folate metabolizing genes with chro-mosome damage and risk of Down syndrome offspring. Neurosci Lett, 2009, 449(1): 15-19.
 Coppedè F. The complex relationship between folate/ ho-mocysteine metabolism and risk of Down syndrome. Mu-tat Res, 2009, 682(1): 54-70.